Onalabs: Pioneering a Paradigm Shift in Healthcare Monitoring
Introduction to Onalabs
Founded a decade ago in Barcelona, Onalabs is making waves in the healthcare sector with its innovative approach to health monitoring. Under the leadership of CEO Elisabet del Valle, the company has dedicated itself to research and development in deep tech, aiming to revolutionize how we monitor our health. The core idea? Transitioning from traditional, sporadic blood tests to a more intensive and continuous monitoring system that utilizes sweat as a diagnostic tool.
Funding for Innovation
To propel its groundbreaking technology into the market, Onalabs has initiated a funding round that has garnered attention not only from private investors but also from the Spanish government. The Ministry for Digital Transformation has committed to investing up to 4.6 million euros through the Spanish Society for Technological Transformation (SETT). This investment represents half of a total funding round of 9.3 million euros, which will also include contributions from private capital.
A New Phase for Onalabs
With a team of around 30 professionals, Onalabs is poised for significant growth. The participation of international investors like 1921 Ventures, which specializes in diabetes technology, and nPrime, with connections across Europe and Asia, underscores the global interest in Onalabs’ innovations. Del Valle describes this moment as a “turning point,” allowing the company to shift from a focus on technological development to one centered on industrialization and international expansion.
Government Support for Disruptive Technologies
The Spanish government’s investment reflects a broader commitment to fostering disruptive technologies and digitalization within the healthcare sector. This initiative is part of SETT’s strategy to encourage public-private collaboration, aiming to position Spain as a leader in digital health solutions. The government believes that Onalabs’ technology has the potential to revolutionize healthcare by providing real-time insights into an individual’s health through the analysis of metabolites found in sweat.
Real-Time Health Monitoring
Onalabs’ technology aims to identify imbalances in the body before they manifest as clinical issues. Del Valle emphasizes that continuous monitoring generates vast amounts of longitudinal data. By leveraging artificial intelligence to analyze this data, Onalabs can identify patterns and anticipate physiological changes, steering the healthcare industry toward a more preventive model.
Applications in Sports and Beyond
Currently, Onalabs has launched a monitoring device tailored for athletes, designed to enhance performance. This device provides real-time biochemical parameters derived from sweat, such as lactate levels, fluid loss, sodium concentration, dehydration levels, and heart rate. This information enables athletes to make informed decisions to minimize risks and optimize their performance during competitions. The company envisions similar devices for monitoring chronic conditions like diabetes and kidney failure, expanding the potential applications of their technology.
Commercialization Plans
Onalabs plans to market two primary products: ONASPORT, aimed at enhancing sports performance, and ONAVITAL, which focuses on clinical applications. The recent funding round is crucial for scaling up production and bringing these products to market both nationally and internationally. Del Valle emphasizes a collaborative approach, stating that Onalabs does not aim to compete with established giants in the industry but rather to form strategic alliances that facilitate the integration of their technology into existing healthcare ecosystems.
Strategic Partnerships
One notable partnership is with FC Barcelona, which invested in Onalabs through its Barça Innovation Hub three years ago. This collaboration not only provides financial backing but also positions Onalabs within a prestigious network that can accelerate the adoption of its technology in sports and health sectors.
The Ministry’s Vision for Economic Growth
The Spanish government views investments in companies like Onalabs as part of a broader strategy to stimulate economic growth. The Ministry for Digital Transformation aims to establish Spain as a European benchmark in digital health. By investing in innovative companies, the government hopes to enhance local manufacturing capabilities for health-focused bioelectronics, reinforcing Spain’s position as a hub for technological advancement in healthcare.
Conclusion
Onalabs stands at the forefront of a healthcare revolution, leveraging innovative technology to transform how we monitor health. With significant backing from both private investors and the Spanish government, the company is well-positioned to make a lasting impact on the healthcare landscape, paving the way for a future where continuous health monitoring becomes the norm.
